DMAC

DiaMedica Therapeutics Inc

DMAC.US diamedica.com + Research + Basket
CIK 0001401040
ISIN CA25253X2077
CUSIP 25253X207
Employees 35
Phone 763 496 5454
Fiscal year end December
IPO Jan 04, 2008
Address 301 Carlson Parkway, Minneapolis, MN, United States, 55305
9.60
-0.22 (-2.24%)
USD · NASDAQ
52-week range
5.25
10.42
Trading at 84% of the 52-week range
Market Cap
529.55M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.71
Div. Yield
N/A
% Institutions
40.92%
% Insiders
27.83%

1 Year

+44.6%

3 Year

+356.7%

10 Year

+149.0%
Description

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Actions

Add an action for DMAC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Dietrich John Pauls MBA President, CEO & Director 1971
Mr. Scott Kellen CPA CFO & Corporate Secretary 1965
Dr. Julie Krop M.D. Chief Medical Officer 1966
Dr. Ambarish Shah Ph.D. Chief Technology Officer NA
Mr. Dominic R. Cundari Chief Commercial Officer 1951

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Nov 25, 2025 Jan Stahlberg N/A Purchase 73.10K $8.57 $626.46K SEC
Nov 24, 2025 Jan Stahlberg N/A Purchase 40.25K $7.89 $317.60K SEC
Nov 21, 2025 Jan Stahlberg N/A Purchase 208.87K $7.41 $1.55M SEC
Nov 20, 2025 Jan Stahlberg N/A Purchase 128.43K $7.41 $951.64K SEC
Nov 19, 2025 Jan Stahlberg N/A Purchase 240.35K $7.21 $1.73M SEC
Nov 18, 2025 Jan Stahlberg N/A Purchase 182.88K $6.75 $1.23M SEC
Nov 17, 2025 Jan Stahlberg N/A Purchase 187.39K $6.52 $1.22M SEC
Aug 27, 2025 Jan Stahlberg N/A Purchase 50.77K $6.00 $304.63K SEC
Aug 26, 2025 Jan Stahlberg N/A Purchase 59.65K $6.00 $357.89K SEC
Aug 25, 2025 Jan Stahlberg N/A Purchase 338.27K $6.00 $2.03M SEC
Aug 22, 2025 Jan Stahlberg N/A Purchase 59.79K $5.96 $356.34K SEC
Aug 21, 2025 Jan Stahlberg N/A Purchase 48.17K $5.96 $287.11K SEC
Aug 20, 2025 Jan Stahlberg N/A Purchase 71.11K $5.86 $416.69K SEC
Aug 15, 2025 Jan Stahlberg N/A Purchase 8.23K $6.00 $49.40K SEC
Aug 14, 2025 Jan Stahlberg N/A Purchase 70.41K $5.99 $421.78K SEC
Aug 13, 2025 Jan Stahlberg N/A Purchase 293.60K $5.91 $1.74M SEC
Jul 23, 2025 Jan Stahlberg N/A Purchase 1.54M $3.50 $5.40M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Cooperman Leon G 3.45M Jun 30, 2026 6.40% $0.68 70.79%
BlackRock Inc 2.25M Jun 30, 2026 4.18% $0.00 21.34%
Geode Capital Management, LLC 894.12K Jun 30, 2026 1.66% $0.00 14.55%
PARAGON Assoc & PARAGON Assoc II JV 875.00K Mar 31, 2026 1.62% $8.05 0.00%
Millennium Management LLC 845.31K Jun 30, 2026 1.57% $0.00 -9.65%
State Street Corp 646.74K Jun 30, 2026 1.20% $0.00 0.39%
Bleichroeder LP 382.32K Jun 30, 2026 0.71% $0.48 0.00%
Vanguard Capital Management, LLC 355.52K Jun 30, 2026 0.66% $0.00 6.62%
Advisor Group Holdings, Inc. 338.11K Jun 30, 2026 0.63% $0.00 5.77%
Northern Trust Corp 327.52K Jun 30, 2026 0.61% $0.00 -3.25%
Vanguard Portfolio Management, LLC 251.67K Jun 30, 2026 0.47% $0.00 23.70%
LPL Financial Corp 233.50K Jun 30, 2026 0.43% $0.00 3.30%
Vanguard Fiduciary Trust Co 207.44K Jun 30, 2026 0.38% $0.00 10.50%
The Goldman Sachs Group Inc 168.07K Jun 30, 2026 0.31% $0.00 183.47%
Citadel Advisors Llc 145.87K Jun 30, 2026 0.27% $0.00 0.10%
Squarepoint Ops LLC 145.25K Jun 30, 2026 0.27% $0.00 0.00%
Bank of New York Mellon Corp 117.82K Jun 30, 2026 0.22% $0.00 6.07%
MEMBERS WEALTH LLC 101.38K Jun 30, 2026 0.19% $0.39 0.00%
Charles Schwab Investment Management Inc 96.69K Jun 30, 2026 0.18% $0.00 9.35%
Cobalt Capital Management Inc 90.00K Jun 30, 2026 0.17% $0.45 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Russell 2000 ETF 938.05K 1.74% ▼ 1.14% Sep 30, 2026
2 Fidelity Small Cap Index 399.64K 0.74% ▲ 0.27% Jul 31, 2026
3 iShares Russell 2000 Growth ETF 347.22K 0.64% ▼ 0.13% Sep 30, 2026
4 Vanguard Russell 2000 ETF 213.59K 0.40% ▲ 1.77% Sep 30, 2026
5 Fidelity Extended Market Index 155.38K 0.29% ▼ 0.53% Aug 31, 2026
6 iShares Micro-Cap ETF 115.58K 0.21% ▼ 0.68% Sep 30, 2026
7 Schwab Small Cap Index 88.39K 0.16% ▲ 0.00% Sep 30, 2026
8 iShares Russell 2000 Small-Cap Idx Instl 68.02K 0.13% ▼ 9.99% Sep 30, 2026
9 Fidelity Total Market Index 60.69K 0.11% ▲ 0.00% Aug 31, 2026
10 Jacob Discovery Fd Instl 59.73K 0.11% ▼ 10.49% Jun 30, 2026

Financial Highlights

▼
Market Cap: $529.55M
EBITDA: $-39.17M
Book Value: $0.71
Earnings/Share: $-0.72
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -64.12%
ROE (TTM): -114.62%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $425.30M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 53.93M
Shares Float: 25.30M
% Insiders: 27.83%
% Institutions: 40.92%
Shares Short: 5.24M
Shares Short (Prior Month): 5.58M
Short Ratio: 21.79
Short % Float: 14.48%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-9.78M
R&D
adjust
$-24.61M
Operating Income
subtotal
$-34.40M
Other / Non-Operating Items
adjust
$1.63M
Net Income
subtotal
$-32.77M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DMAC.US!